CMS-0057-F · January 1, 2027
The Payer-to-Payer API in 2027 is a data depth problem
Applies to Medicare Advantage, Medicaid and CHIP (fee-for-service and managed care), and qualified health plans on the federal exchanges — not traditional Medicare, not employer plans. Prescription drug prior authorization is excluded.
When a member moves between plans, up to five years of claims, clinical and prior authorization history has to follow, on request, with opt-in consent. Most of the work is consent capture, member matching and a backfill nobody scoped.
What has to be true
A member-requested exchange covering up to five years of claims, clinical and prior authorization data.
Opt-in consent captured and evidenced, not assumed from enrolment.
Member matching precise enough that the history attached is the right person's.
Deduplication on ingest, because the same encounter will arrive from more than one source.
Where implementations break
Consent recorded as a boolean with no evidence trail.
Member matching that works on the happy path and merges siblings on the others.
Backfill depth agreed in principle and never tested — the fifth year is usually missing.
No dedupe, so the member's record doubles on every transfer.
How it gets tested
Da Vinci PDex conformance for the exchanged bundles.
Consent evidence sampled per transfer, with the member's request attached.
Backfill completeness checked year by year against the source system.
Consent evidence, matching and backfill
Opt-in consent must be capturable and provable per transfer, with the member's request attached to the evidence. A boolean is not consent evidence.
Historical depth is the part that slips: agree the five years, then test year five explicitly, because that is the year the source system archived.
Deduplicate on ingest or the member's record doubles at every transfer.
Frequently asked
How much history?
Up to five years of claims, clinical and prior authorization data, excluding denied requests and drug authorizations as the rule specifies.
Who initiates?
The member, through the receiving plan, with opt-in consent.
What does the assessment cost?
$12,000 fixed, ten business days, written findings.
What data is excluded?
Denied prior authorization requests and drug authorizations are excluded from the history the rule requires; the assessment checks that the exclusion is applied deliberately rather than by omission.